阿法骨化醇
外觀
阿法骨化醇 | |
---|---|
IUPAC名 (1R,3S,5Z)-4-Methylidene-5-[(2E)-2-{(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]octahydro-4H-inden-4-ylidene}ethylidene]cyclohexane-1,3-diol | |
別名 | Alphacalcidol; 1-Hydroxycholecalciferol |
識別 | |
CAS號 | 41294-56-8 |
PubChem | 5282181 |
ChemSpider | 4445376 |
SMILES |
|
InChI |
|
InChIKey | OFHCOWSQAMBJIW-AVJTYSNKBM |
ChEBI | 31186 |
DrugBank | DB01436 |
KEGG | D01518 |
性質 | |
化學式 | C27H44O2 |
莫耳質量 | 400.64 g/mol g·mol⁻¹ |
熔點 | 136 °C(409 K) |
溶解性(水) | 0.016 g/100 mL |
藥理學 | |
ATC代碼 | A11CC03(A11) |
藥品分級 | |
藥品許可證 | |
若非註明,所有數據均出自標準狀態(25 ℃,100 kPa)下。 |
阿法骨化醇(英語:Alfacalcidol,也稱為1-羥基膽鈣化醇,1-hydroxycholecalciferol)是一種含氮有機化合物,化學式C27H44O2,屬於維生素D類似物[3]。
參考文獻
[編輯]- ^ One-Alpha Capsules - Summary of Product Characteristics (SmPC). (emc). 9 November 2017 [17 February 2021]. (原始內容存檔於2024-02-25).
- ^ List of nationally authorised medicinal products (PDF). ema.europa.eu. 11 February 2021 [14 April 2023].
- ^ Cavalli L, Cavalli T, Marcucci G, Falchetti A, Masi L, Brandi ML. Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women. Clinical Cases in Mineral and Bone Metabolism. May 2009, 6 (2): 169–73. PMC 2781231 . PMID 22461169.